Delivery Order SPE2DB20D9331-SPE2DB22FL0L0

Award Date 1/14/22
Potential Completion Date 1/18/22
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,014.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Altafluor Benox 0.25%-0.4% eye drops in 5 milliliter vials, with a period of performance through November 1, 2024. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,042.00 contract is for the supply of Altafluor Benox 0.25%-0.4% ophthalmic drops. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,028.48, is for the supply of Altafluor Benox 0.25%-0.4% eye drops in 5ml containers. The contract has an ultimate completion date of April 18, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.40 contract is for the delivery of Altafluor Benox 0.25%-0.4% Drops 5ml, a specialized pharmaceutical product, with a completion date of March 17, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,014.24 firm fixed-price delivery order is for the supply of an ophthalmic drug, Altafluor Benox 0.25%-0.4% Eye Drops, 5 mL, to support the medical supply needs of the Department of Defense (DoD). This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,014.00, was awarded on June 7, 2023, by the Defense Logistics Agency (DLA) for the supply of a pharmaceutical product, Altafluor Benox 0.25%-0.4% Ophthalmic Drops, 5 ml. The contract has an ultimate completion date of June 8, 2023. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a ceiling value of $1,014.24. The order is for the drug Altafluor Benox 0.25%-0.4% ophthalmic drops, with a period of performance through March 14, 2024. DMS Pharmaceutical Group holds a larger $4,999,999 indefinite delivery contract with DLA, contract SPE2DB0048, under the DLA's Pharmaceutical Prime Vendor program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price valued at $1,014.00 for the supply of an ophthalmic medication called Altafluor Benox 0.25%-0.4% DRP 5ML. The contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,816.75 contract is for the supply of ALTAFLUOR BENOX 0.25%-0.4% DRP 5ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,028.48 contract is for the delivery of ALTAFLUOR BENOX 0.25%-0.4% DRP 5ML and has a completion date of September 9, 2024. The award is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the agency to issue firm fixed-price...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB22FL0L0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,696.00 firm fixed-price contract is for the supply of Altafluor Benox 0.25%-0.4% eye drops in 5 milliliter vials.

The contract is not associated with a set-aside program and is part of a larger $499,999,999 indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program. This IDC covers a comprehensive range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the recurring medical needs of Department of Defense healthcare facilities worldwide.

DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain is further strengthened by this delivery order, which complements the company's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites.

Generated 1/9/25, 9:31 AM